Physician profile
John J Lopez
NPI 1669534111
$63,787.78
in general payments reported to CMS, 2019-2025
17 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,069 · 2020: $3,376 · 2021: $8,811 · 2022: $10K · 2023: $13K · 2024: $16K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Travel and Lodging: $4,198 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Food and Beverage: $3,709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $27,650.00 |
| Travel and Lodging | $4,198.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Food and Beverage | $3,709.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $43,907.33 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbott Laboratories | $12,269.66 | 2019-2025 | Dragonfly Opstar, Ultreon, Diamondback Coronary |
| Philips North America LLC | $2,100.00 | 2021 | |
| Medtronic, INC. | $2,054.42 | 2022-2025 | Corevalve Evolut R, In.Pact Admiral, Endurant Iis |
| Biotronik INC. | $1,400.23 | 2019-2024 | Orsiro Mission |
| Teleflex LLC | $808.62 | 2025 | Manta, Guideliner |
| Inari Medical, INC. | $477.08 | 2023-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $276.54 | 2020-2024 | Impella |
| Medtronic Vascular, INC. | $219.18 | 2019-2020 | |
| Penumbra, INC. | $100.00 | 2023 | Red 72 |
| Teva Pharmaceuticals USA, INC. | $35.94 | 2025 | Uzedy |
| Opsens INC. | $33.16 | 2022 | |
| Shockwave Medical, INC | $29.08 | 2025 | |
| Amgen INC. | $25.98 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $18.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $16.90 | 2024 | |
| Novartis Pharmaceuticals Corporation | $14.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.